Comparing between injection triamcinolone and injection verapamil for treatment of keloids and to know how safe they are.

Interventional study comparing intralesional verapamil and intralesional triamcinolone acetonide in the treatment of keloids in a tertiary care hospital. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061273

Enrollment

Registered

2024-01-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

Intervention1: injection triamcinolone acetonide: Giving intralesional triamcinolone acetonide 40 mg/ml in first keloid with the help of insulin syringe and injecting 4 units per cm of keloid , at in

Eligibility

Inclusion criteria

Inclusion criteria: 1.Keloid patients aged between 18 and 70 years old. 2.Patients having more than or equal to two keloids.

Exclusion criteria

Exclusion criteria: 1.Patients with evidence of any infection (in or near the scar area) 2.Patient with a history of cardiovascular problems, pregnant women. 3.Patient received any intralesional over keloids in past 1 months 4.Patient who didn’t give informed consent for this treatment

Design outcomes

Primary

Measure	Time frame
To assess and compare the efficacy of: intralesional verapamil hydrochloride and triamcinolone acetonide in treatment of keloid in patient aged 18 to 70 years.Timepoint: one year	—

Secondary

Measure	Time frame
To assess the safety of: intralesional verapamil hydrochloride & triamcinolone acetonide in treatment of keloid in patient aged 18 to 70 yearsTimepoint: one year	—

Countries

India

Contacts

Public ContactDr. Vijaya Sajjjan

Jawaharlal Nehru Medical College

vijaya_sajjan@yahoo.com9880503069

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026